ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models.

Giovanni Luca Gravina et al.PubMed ↗Publisher ↗

No numbers read from the abstract.